|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han P, Wang QL and Zhang X: Expression of
TRAP1 in gastric cancer tissue and its correlation with malignant
biology. Asian Pac J Trop Med. 9:67–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi HJ, Ki CS, Suh SP and Kim JW:
Presymptomatic identification of CDH1 germline mutation in a
healthy korean individual with family history of gastric cancer.
Ann Lab Med. 34:386–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma B, Xu Q, Song Y, Gao P and Wang Z:
Current issues of preoperative radio(chemo)therapy and its future
evolution in locally advanced rectal cancer. Future Oncol.
13:2489–2501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robertson-Tessi M, Gillies RJ, Gatenby RA
and Anderson AR: Impact of metabolic heterogeneity on tumor growth,
invasion, and treatment outcomes. Cancer Res. 75:1567–1579. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ben Nasr S, Ayadi M, Bahloul R, Guesmi S,
Allani B, Chrait N, Rifi H, Rais H and Mezlini A: Perioperative
chemotherapy in locally advanced gastric cancer. A retrospective
study about 25 cases. Tunis Med. 93:228–230. 2015.PubMed/NCBI
|
|
8
|
Peters GJ, Backus HH, Freemantle S, van
Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J,
Calvert AH, Marsh S, et al: Induction of thymidylate synthase as a
5-fluorouracil resistance mechanism. Biochim Biophys Acta.
1587:194–205. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng H, Peng N, Yu M, Sun X, Ma Y, Yang G
and Wang X: Treatment of triple-negative breast cancer with Chinese
herbal medicine: A prospective cohort study protocol. Medicine
(Baltimore). 96:e84082017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai YT, Lai JN, Lo PC, Chen CN and Lin
JG: Prescription of Chinese herbal products is associated with a
decreased risk of invasive breast cancer. Medicine (Baltimore).
96:e79182017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Liang Y and He C: Anticancer
activities and mechanisms of heat-clearing and detoxicating
traditional Chinese herbal medicine. Chin Med. 12:202017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rashid N, Koh HA, Baca HC, Lin KJ, Malecha
SE and Masaquel A: Economic burden related to chemotherapy-related
adverse events in patients with metastatic breast cancer in an
integrated health care system. Breast Cancer (Dove Med Press).
8:173–181. 2016.PubMed/NCBI
|
|
13
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohno N, Miura T, Saito K, Nishijima M,
Miyazaki T and Yadomae T: Physicochemical characteristics and
antitumor activities of a highly branched fungal
(1–3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens. Chem
Pharm Bull (Tokyo). 40:2215–2218. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen YT, Lu QY, Lin MA, Cheng DQ, Ding ZS
and Shan LT: A PVP-extract fungal protein of Omphalia lapideacens
and its antitumor activity on human gastric tumors and normal
cells. Oncol Rep. 26:1519–1526. 2011.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ouyang J, Pan X, Lin H, Hu Z, Xiao P and
Hu H: GKN2 increases apoptosis, reduces the proliferation and
invasion ability of gastric cancer cells through down-regulating
the JAK/STAT signaling pathway. Am J Transl Res. 9:803–811.
2017.PubMed/NCBI
|
|
18
|
Zhang Y, Pan T, Zhong X and Cheng C:
Androgen receptor promotes esophageal cancer cell migration and
proliferation via matrix metalloproteinase 2. Tumour Biol.
36:5859–5864. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dou CY, Cao CJ, Wang Z, Zhang RH, Huang
LL, Lian JY, Xie WL and Wang LT: EFEMP1 inhibits migration of
hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2
activity. Oncol Rep. 35:3489–3495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: 2-Deoxyglucose and sorafenib
synergistically suppress the proliferation and motility of
hepatocellular carcinoma cells. Oncol Lett. 13:800–804. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma J, Fu G, Wu J, Han S, Zhang L, Yang M,
Yu Y, Zhang M, Lin Y and Wang Y: 4-cholesten-3-one suppresses lung
adenocarcinoma metastasis by regulating translocation of HMGB1,
HIF1α and caveolin-1. Cell Death Dis. 7:e23722016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edatt L, Haritha K, Sruthi TV, Aswini P
and Sameer Kumar VB: 2-Deoxy glucose regulate MMP-9 in a SIRT-1
dependent and NFkB independent mechanism. Mol Cell Biochem.
423:197–206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Radunovic M, Nikolic N, Milenkovic S,
Tomanovic N, Boricic I, Dimitrijevic M, Novakovic I and
Basta-Jovanovic G: The MMP-2 and MMP-9 promoter polymorphisms and
susceptibility to salivary gland cancer. J BUON. 21:597–602.
2016.PubMed/NCBI
|
|
24
|
Xu W and McArthur G: Cell cycle regulation
and melanoma. Curr Oncol Rep. 18:342016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hartwell LH and Kastan MB: Cell cycle
control and cancer. Science. 266:1821–1828. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen X, Wu Z, Chen S, Chen Y, Xia J, Lv Y
and Zhou Y: Induction of G2/M phase arrest and apoptosis by ZGDHU-1
in A549 and RERF-LC-MA lung cancer cells. Oncol Lett. 12:989–994.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shimura T, Fukumoto M and Kunugita N: The
role of cyclin D1 in response to long-term exposure to ionizing
radiation. Cell Cycle. 12:2738–2743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loukil A, Cheung CT, Bendris N, Lemmers B,
Peter M and Blanchard JM: Cyclin A2: At the crossroads of cell
cycle and cell invasion. World J Biol Chem. 6:346–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li YL, Zhang J, Min D, Hongyan Z, Lin N
and Li QS: Anticancer effects of
1,3-dihydroxy-2-methylanthraquinone and the ethyl acetate fraction
of hedyotis diffusa willd against HepG2 carcinoma cells mediated
via apoptosis. PLoS One. 11:e01515022016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tamm I, Schriever F and Dörken B:
Apoptosis: Implications of basic research for clinical oncology.
Lancet Oncol. 2:33–42. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Azadmehr A, Hajiaghaee R, Baradaran B and
Haghdoost-Yazdi H: Apoptosis cell death effect of scrophularia
variegata on breast cancer cells via mitochondrial intrinsic
pathway. Adv Pharm Bull. 5:443–446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu BS, Zhao K, Jia X, Wu YY and Xing CG:
Effects of damage-regulated autophagy regulator gene on the SGC7901
human gastric cancer cell line. Oncol Lett. 8:657–662. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao K, Zhu BS, Gong W, Zhu ML, Gao ZT, Wu
YY, Chen Q, Yang XD and Xing CG: SN50 enhances the effects of
LY294002 on cell death induction in gastric cancer cell line
SGC7901. Arch Med Sci. 9:990–998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu G, Xiang T, Wu QF and Wang WX:
Curcumin suppresses the proliferation of gastric cancer cells by
downregulating H19. Oncol Lett. 12:5156–5162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Xu J, Wang X and Yuan G: Protective
effect of ginsenoside Rg1 on lidocaine-induced apoptosis. Mol Med
Rep. 9:395–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu B, Lu Y, Li J, Liu Y, Liu J and Wang
W: Leukemia inhibitory factor promotes tumor growth and metastasis
in human osteosarcoma via activating STAT3. APMIS. 123:837–846.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yeh JE and Frank DA: STAT3-interacting
proteins as modulators of transcription factor function:
Implications to targeted cancer therapy. ChemMedChem. 11:795–801.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brambilla L, Genini D, Laurini E, Merulla
J, Perez L, Fermeglia M, Carbone GM, Pricl S and Catapano CV:
Hitting the right spot: Mechanism of action of OPB-31121, a novel
and potent inhibitor of the signal transducer and activator of
transcription 3 (STAT3). Mol Oncol. 9:1194–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Khanna P, Chua PJ, Bay BH and Baeg GH: The
JAK/STAT signaling cascade in gastric carcinoma (Review). Int J
Oncol. 47:1617–1626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mukherjee A and Khuda-Bukhsh AR: Quercetin
down-regulates IL-6/STAT-3 signals to induce mitochondrial-mediated
apoptosis in a nonsmall-cell lung-cancer cell line, A549. J
Pharmacopuncture. 18:19–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu RX, Hu XM, Xu SQ, Jiang ZJ and Yang W:
Effects of fucoxanthin on proliferation and apoptosis in human
gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway.
Eur J Pharmacol. 657:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang C and Xie K: Crosstalk of Sp1 and
Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth
Factor Rev. 23:25–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kijima T, Niwa H, Steinman RA, Drenning
SD, Gooding WE, Wentzel AL, Xi S and Grandis JR: STAT3 activation
abrogates growth factor dependence and contributes to head and neck
squamous cell carcinoma tumor growth in vivo. Cell Growth Differ.
13:355–362. 2002.PubMed/NCBI
|
|
44
|
Masuda M, Suzui M, Yasumatu R, Nakashima
T, Kuratomi Y, Azuma K, Tomita K, Komiyama S and Weinstein IB:
Constitutive activation of signal transducers and activators of
transcription 3 correlates with cyclin D1 overexpression and may
provide a novel prognostic marker in head and neck squamous cell
carcinoma. Cancer Res. 62:3351–3355. 2002.PubMed/NCBI
|
|
45
|
Sinibaldi D, Wharton W, Turkson J, Bowman
T, Pledger WJ and Jove R: Induction of p21WAF1/CIP1and cyclin D1
expression by the Src oncoprotein in mouse fibroblasts: Role of
activated STAT3 signaling. Oncogene. 19:5419–5427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghosh A, Pechota A, Coleman D, Upchurch GR
Jr and Eliason JL: Cigarette smoke-induced MMP2 and MMP9 secretion
from aortic vascular smooth cells is mediated via the Jak/Stat
pathway. Hum Pathol. 46:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang F, Wang Z, Fan Y, Xu Q, Ji W, Tian R
and Niu R: Elevated STAT3 signaling-mediated upregulation of
MMP-2/9 confers enhanced invasion ability in multidrug-resistant
breast cancer cells. Int J Mol Sci. 16:24772–24790. 2015.
View Article : Google Scholar : PubMed/NCBI
|
